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Abstract
Background: This study explored consumer perceptions of complementary and alternative medicine (CAM) and
relationships with CAM and conventional medicine practitioners.
A problem detection study (PDS) was used. The qualitative component to develop the questionnaire used a CAM
consumer focus group to explore conventional and CAM paradigms in healthcare. 32 key issues, seven main
themes, informed the questionnaire (the quantitative PDS component - 36 statements explored using five-point
Likert scales.)
Results: Of 300 questionnaires distributed (Brisbane, Australia), 83 consumers responded. Results indicated that
consumers felt empowered by using CAM and they reported positive relationships with CAM practitioners. The
perception was that CAM were used most effectively as long-term therapy (63% agreement), but that conventional
medicines would be the best choice for emergency treatment (81% agreement). A majority (65%) reported that
doctors appeared uncomfortable about consumers’ visits to CAM practitioners. Most consumers (72%) believed that
relationships with and between health practitioners could be enhanced by improved communication. It was
agreed that information sharing between consumers and healthcare practitioners is important, and reported that
“enough” information is shared between CAM practitioners and consumers. Consumers felt comfortable discussing
their medicines with pharmacists, general practitioners and CAM practitioners, but felt most comfortable with their
CAM practitioners.
Conclusions: This PDS has emphasized the perceived importance of open communication between consumers,
CAM and conventional providers, and has exposed areas where CAM consumers perceive that issues exist across
the CAM and conventional medicine paradigms. There is a lot of information which is perceived as not being
shared at present and there are issues of discomfort and distrust which require resolution to develop concordant
relationships in healthcare. Further research should be based on optimisation of information sharing, spanning
both conventional and CAM fields of healthcare, due to both the relevance of concordance principles within CAM
modalities and the widespread use of CAM by consumers.
Background
The use of, and beliefs in, complementary and alternative
medicine (CAM) versus conventional therapies can be
culturally determined, sometimes ignoring individual
consumers’ preferences, rights and needs [1,2]. CAM is a
term used for treatments which are not considered part
of conventional medicine, including herbal medicines,
acupuncture and others. However, conventional and
CAM services are being integrated by some types of
healthcare practitioners [3-5]. This includes many phar-
macists who supply CAM treatments and who are in a
position to promote quality use of these medicines, in
accordance with the National Medicines Policy in
Australia [6,7].
Bringing CAM into the mainstream is viewed by some
as a way of reinstating focus on the consumer - the per-
son, not the disease [8,9]. This is consistent with
another trend - the increasing focus on ‘concordance’ in
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relationships between healthcare practitioners and con-
sumers in the conventional healthcare model [10]. Con-
cordance is based on negotiation between partners in a
therapeutic relationship (consumer and healthcare prac-
titioners), its strength being respect for the consumer’s
agenda and the creation of openness in the relationship
[11-14]. CAM is increasingly a reality in healthcare, and
one aspect in which concordant relationships may be
particularly valuable is around integration of the CAM
and conventional medicine paradigms [15-19].
Despite the growing body of literature surrounding
concordance, there is a lack of published research explor-
ing concordance in relation to CAM. Research to date on
the opinions of healthcare practitioners and consumers
has historically been concerned mainly with what health-
care practitioners want to know about the relationships
between consumers and healthcare practitioner, and
their perceptions of the issues consumers were facing in
relation to both conventional and CAM treatment mod-
alities [5,17,20-23]. A need for more research about
concordance and CAM focusing on the consumer
perspective is evident.
The aim of the present study was to explore the per-
ceptions and understanding of self-selected CAM consu-
mers on concordance and experiences with conventional
medicine practitioners (general practitioners (GPs) and
pharmacists) and CAM practitioners. This paper explores
a group of self-selected CAM consumer perspectives -
their views, perceptions, beliefs and experiences in rela-
tion to concordance, CAM and conventional medicines
use.
Methods
Problem-Detection Study (PDS) methods were applied;
these originated in marketing and advertising research,
and are gaining acceptance in many areas of social health
research [24-28]. This method combines qualitative data
collection (often using focus groups or interviews) to
explore the meanings that people ascribe to their situa-
tions and their perceptions of significance, and then
quantitative data collection (usually a more widely-admi-
nistered questionnaire) for numerical data, often used for
comparative analysis between different groups [29-31].
The concept of problem identification arising from differ-
ing perceptions of the same issue/statement is very useful
for future intervention design and evaluation. The princi-
ple behind this PDS was to investigate similarities and
differences between consumers’ ratings of issues relating
to CAM and concordance compared to those rated by
healthcare practitioners in a previous study, reported
elsewhere [10].
This study was granted ethical approval by the Human
Research Ethics Committee (number 2005/6) of the
School of Pharmacy, The University of Queensland (JF
was a postgraduate student at the time). Focus group
participants gave written consent, and implied consent
was given by participants choosing to complete the
questionnaire. All participants could withdraw at any
time without consequences, and all data were de-
identified.
Focus group with consumers of CAM
A focus group was conducted with CAM consumers to
gather information on participants’ thoughts and experi-
ences in an environment that provided an opportunity
for participants to freely share their thoughts and ideas
on a wide range of issues [31-34]. The CAM consumers
were recruited through a written advertisement in three
health-food stores, three CAM practices, and three phar-
macies in inner-city Brisbane, Australia, over a period of
one month. These sites enabled purposive sampling for
the purposes of a focused discussion. The inclusion cri-
teria were that the participants could recall using a CAM
(very openly defined as ‘natural’ or complementary medi-
cine bought from a pharmacy, health food store or super-
market), were conversant in English, and were aged at
least 18 years. This recruitment method was a combina-
tion of convenience and purposive sampling to ensure
that the participants were likely to be capable of provid-
ing answers within the topic being researched [31,32].
Nine CAM consumers (seven females and two males)
were recruited for the focus group, which is comparable
with other studies [31-34]. The facilitator of the focus
group (LE) encouraged participation and maintained
relevance of the discussion. A researcher (JF) was present
as an observer and note-taker. Simple starter (’seed’)
questions, derived from concordance, CAM, and litera-
ture relating to focus group research, were formulated in
a non-leading and non-suggestive way to ensure that
they did not unduly influence the participants’ own agen-
das and opinions [35]. The focus group was recorded and
later transcribed verbatim by a researcher (JF). The tran-
script was thematically analysed manually into the key
issues by a researcher (JF) and checked independently by
the co-researchers (LE, ST) to minimise subjectivity of
interpretation. Thirty-two key issues were identified by
manual thematic analysis from this process in combina-
tion with interviews (10 general practitioners) and focus
groups (9 pharmacists) with health professionals (as
detailed elsewhere [10]).The identified issues from the
consumer focus group (in conjunction with those from
the health professional groups, reported elsewhere [10])
were then thematically analysed and summarised manu-
ally through a systematic process of data reduction into
seven themes by a researcher (JF) [30,31]. No particular
number of themes was sought in this analysis. The accu-
racy of this data reduction was also checked indepen-
dently by researchers LE and ST to minimise personal
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interpretation bias [30,31]. These themes were used to
develop the questionnaire (below), as described pre-
viously [10]. A single CAM consumer focus group was
used as data were also collected from the other groups to
extract the themes and develop the statements. In total
sufficient data were obtained for the extraction and
theme development, the purpose of this initial qualitative
stage of the PDS.
Quantitative data collection phase
The quantitative component of the PDS was undertaken
via a self-completed questionnaire by the relevant popu-
lation; this approach mirrored other PDS reports [24-28].
The questionnaire development was informed by the
focus group data (from the seven themes developed as
described above). Thirty-six statements (corresponding
to the seven themes, given in Table legends) (Tables 1, 2,
3, 4, 5, 6 and 7) were developed and a five-point Likert
scale applied: ‘strongly agree’, ‘agree’, ‘neutral’, ‘disagree’,
and ‘strongly disagree’ (with a separate ‘not applicable/
don’t know’ option). The seven themes were described
through several statements each until the researchers felt
that the statements sufficiently and comprehensively
described the themes. It was not the intention of the
researchers to have equal numbers of statements for each
theme, but rather for the themes to be sufficiently out-
lined in the statements (e.g. the number of statements
corresponding to the themes ranges from 3 to 8 per
theme).
Wording was tailored to consumers, the statements
were randomised, and the questionnaires were anon-
ymous and coded. Pilot testing for face validity involved
five consumers. The survey proper was distributed over
three months (determined by diminishing returns) via
CAM practitioners’ waiting rooms, community pharma-
cies, and health-food stores in Brisbane, Australia. The
questionnaire was collected by/given to consumers to
complete and return (postage paid). The inclusion cri-
teria were that the consumers could recall ever having
used a CAM or could recall having visited a CAM practi-
tioner (again, this was not rigidly defined for them but
left open as ‘natural’ or complementary medicines or nat-
uropaths, herbalists or other complementary and alterna-
tive medicine (CAM) practitioners). This study applied
purposive and convenience sampling methods to ensure
that the participants were likely to be capable of provid-
ing answers within the topic being researched [30,31]. It
was not the aim of this explorative research to provide
data generalisable to the whole population, but rather to
examine the data relating to particular populations of
respondents interested in the topic [30,31]. A target sam-
ple size of 100-150 consumers and anticipated response
rate of less than 50% required the distribution of 300
questionnaires. Due to the anonymous nature of the
questionnaire and the modes of distribution, there was
no follow-up of non-respondent consumers, and no
incentives were provided to respondents. A self-
addressed postage paid envelope was attached to each
questionnaire to facilitate return [31].
The data analysis, described in detail previously [10],
involved complete data screening during and after data
entry, random checking of the data entry accuracy, analy-
sis of the demographic (categorical) data, and descriptive
analysis of the 36 statements (medians and frequencies of
response options). Identified issues were then compared,
also comparing to group data already published [10], and
common trends noted. The findings below report the
consumer perspective, including a short discussion









I am encouraged to share the same type of personal health information with my doctor as with my
CAM practitioner.
56 5 39 82
I lose confidence in the success of my treatment if I cannot spend enough time in consultation with
my healthcare practitioners (conventional and/or CAM).
83 7 10 81
I am given enough information about benefits of my CAM treatment to feel confident about the
treatment(s).
76 18 6 82
I am given enough information about risks of my CAM treatment to be confident about the
treatment(s).
66 20 14 80
I am given enough information about benefits of my conventional treatment to feel confident about
the treatment(s).
32 19 49 83
I am given enough information about risks of my conventional treatment to feel confident about the
treatment(s).
45 13 42 82
I am satisfied with the amount of information exchange between me and my conventional health
practitioners at present.
37 17 46 83
I am satisfied with the amount of information exchange between me and my CAM practitioners at
present.
79 11 10 82
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contextualising the consumer perspectives against the
key findings from the three groups of health professionals
previously surveyed (pharmacists, GPs, CAM practi-
tioners [10]).
Results
A 28% response (83 of 300 questionnaires distributed)
was obtained for the consumer participants. More
females (58) than males (25) responded. The majority of
the consumers were middle-aged (47% aged 35-54 years,
n = 47; 21 consumers were 34 or under and 15 were
older than 55).
Tables 1, 2, 3, 4, 5, 6, and 7 represent the responses to
each statement from the consumer group. The state-
ments are classified under the corresponding seven
themes and shown as worded for the consumers. ‘Don’t
know/not applicable’ responses are excluded from the
tabulated results, and for ease of interpretation and tak-
ing into account the sample size, the ‘strongly agree/
agree’ and the ‘strongly disagree/disagree’ categories
have been collapsed into single categories ‘agreement’
and ‘disagreement’, respectively.
There was general agreement with the importance of
information sharing between consumers and healthcare
practitioners, and a reported belief that “enough” infor-
mation is shared between CAM practitioners and consu-
mers (Table 1).
There was a reported belief amongst the consumers
(67%) that their choice to use CAM was not respected
by health professionals, however they felt better
acknowledged by their CAM practitioner than by their
medical doctor. Overall, the consumers felt most
empowered by their relationship with their CAM practi-
tioner(s) and least empowered by their relationship with
their pharmacist(s) (Table 2).
Consumers demonstrated willingness (84% in agree-
ment) to be actively involved in their healthcare, as evident
in the statement “I would like to take more responsibility
for my treatment by getting more involved in every aspect
of it (lifestyle and drug treatment)“, and felt that they were
quite encouraged to do so by the CAM practitioners
(Table 3). As CAM consumers, they considered them-
selves to be more empowered than people who were not
using CAM.
Most consumers also wished to be informed about
effective treatments, and believed in historical effective-
ness of CAM. Some consumers (24%) believed that the
Australian government only allowed the sale of effective
CAM, although the majority did not report an opinion
(Table 4).
The opinion was expressed that CAM are used most
effectively as long-term therapy (63% in agreement), but
less agreement that this would be for treatment as well as
for prevention (35% in agreement), but the opinion also
was that conventional medicines would still be the best
choice for emergency treatment (81% in agreement)
(Table 5). The majority of consumer respondents (65%)
reported that they perceived that conventional doctors









I feel that my choice to use CAM is respected by all health professionals involved in my care. 18 15 67 79
I feel better acknowledged by my CAM practitioner than by my medical doctor. 58 21 21 81
My partnership(s) with my medical doctor(s) empowers me as a consumer more than my partnership
(s) with my CAM practitioner(s).
6 27 67 79
My partnership(s) with my pharmacist(s) empowers me as a consumer more than my partnership(s)
with my CAM practitioner(s).
8 20 72 80
My partnership(s) with my pharmacist(s) empowers me as a consumer more than my partnership(s)
with my medical doctor(s).
20 23 57 81









My healthcare practitioners (conventional and/or CAM) have all the necessary information needed to
make decisions about my treatment without my direct involvement.
11 7 82 83
I prefer making treatment choices by myself when I receive enough information on the treatment
from my health practitioners (conventional and/or CAM).
82 16 2 82
My medical doctor encourages my input into treatment decisions more than my CAM practitioner. 5 20 75 77
Consumers who use CAM are more empowered in their treatment than the consumers who use
solely conventional medicines.
77 15 8 82
I would like to take more responsibility for my treatment by getting more involved in every aspect of
it (lifestyle and drug treatment).
84 12 4 81
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felt uncomfortable about consumers’ visits to CAM prac-
titioners. They also indicated that they thought CAM
practitioners had a high level of knowledge about CAM
and pharmacists did not. Most consumers (72%) believed
that CAM and conventional practitioners need open
channels of communication (Table 6).
Consumers, on the whole, felt that they were more
satisfied with their partnerships with CAM practitioners
than their partnerships with their medical doctors, and
they were least satisfied with their partnerships with
their pharmacists. Consumers felt comfortable discuss-
ing their medicines with all three groups of health prac-
titioners, but were most comfortable with their CAM
practitioners (Table 7).
Discussion
This PDS adds to the field by exploring perceptions
about concordance, CAM and conventional medicine
use and the views of self-selected CAM users about
CAM and conventional health providers. It is then pos-
sible to compare and contrast these data with the same
information collected from conventional healthcare pro-
viders [10] and consumers of conventional medicines to
detect important areas of similarities and differences in
perceptions between groups. This detection of contrasts
and similarities can then assist in developing future
innovations to bridge gaps in understanding and
enhance holistic healthcare.
The majority of CAM consumers surveyed in this PDS
were of the view that there was insufficient information
exchanged between consumers and conventional medi-
cine practitioners, which contrasted with their majority
view that there was sufficient mutual information
exchange between consumers and CAM practitioners.
The surveyed consumers’ perceptions of not being
acknowledged by the GP can potentially have serious
ramifications, since this can also cause consumers not
to disclose their CAM use [23,36]. Literature supports
the notion that the use of CAM is not sufficiently dis-
cussed between doctors and their patients during con-
sultation [37-39], with disclosure of CAM use to doctors
by their patients occurring in around 60-70% of cases
[40,41], while an Australian study reported CAM use
being reported to the medical practitioner in only fewer
than half of the cases [42]. It has been reported that
consumers who experience a more participatory style of
consultation with conventional practitioners tend to be
more likely to also reveal that they are using CAM [36].
It has also been reported that even when the patients
were willing to discuss CAM with their doctor, the doc-
tor still may not feel comfortable about it [17]. In addi-
tion, interestingly, it has been shown that doctors tend
to be uncomfortable about collaborating with CAM
practitioners even when they work in the same hospital
teams [43]. On the other side of the spectrum, an
American study indicated that some family doctors pre-
ferred to call themselves ‘holistic’ and align themselves
with CAM in order to attract more consumers [44].
Further, it has been found that doctors sometimes tend
to report high acceptance of CAM, even though their
knowledge of them was, self-reportedly, quite poor,
creating a potentially dangerous situation [45]. Conver-
sely, some CAM practitioners are indeed willing to work
with conventional medicine practitioners in seeking a
patient-centred integrated health system [3]. There is
probably still quite a way to go to achieve true colla-
boration and open communication in interprofessional
relationships in healthcare [46]. Our previous study also
indicated that all practitioners (conventional and CAM)
valued communication, but that their understanding of
each other’s roles tended to be dubious and inadequate,
adversely affecting the necessary first step in their rela-
tionship building [10].
The surveyed consumers, on the whole, thought that
their partnerships with CAM practitioners were more
empowering to consumers than consumers’ partnerships









Being informed about the treatment is not important if the treatment is working for me. 15 9 76 81
CAM medicines are effective because they have been used for hundreds of years. 58 26 16 76
The Australian Government only allows sale of CAM medicines that have been shown to be effective. 24 35 41 71









The most effective use of CAM is as long-term therapy. 63 19 18 78
CAM are best used to prevent disease rather than treat disease. 35 16 49 80
Conventional medicines are the best choice for emergency treatment. 80 16 4 80
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with pharmacists and doctors. Similarly, a German study
reported that patients using CAM appeared to be more
closely involved in the decision-making process,
reported more satisfaction with treatments, and felt
more acknowledged than conventionally-treated patients
[47]. The finding that our sample of consumers reported
more empowering relationships with doctors than with
pharmacists was surprising, given repeated data support-
ing pharmacists as one of the most trusted professions
[48]. Perhaps empowerment is best generated through
more formal consultations (doctors’ surgery, naturopath
clinic), or through remunerated consultations.
Most respondents felt that they, CAM consumers,
were more empowered than non-CAM consumers. The
CAM consumer responders tended to value longer con-
sultations with their CAM practitioner(s), the ‘whole
person’ approach, mutual respect and sharing decisions,
all of which encourages their perception of being
empowered [49]. Further, it has been reported that the
majority of patients who prefer a patient-centred
approach also preferred CAM use, and vice versa [50].
However, another study found that there was no statisti-
cally significant difference between users and non-users
of CAM with respect to their preferred role in health-
care [51].
A study applying patient profiling in consumers’ deci-
sion making on CAM use suggested that it is possible
that there are not just alternative therapies but ‘alterna-
tive patients’ - people who are simply more inclined to
use CAM [52]. Identifying these patients early could
help healthcare practitioners to optimise their advice on
treatment options and to approach these patients in a
suitable way [52]. This early identification could also be
utilised to open the channels of communication and
increase the chance of achieving mutually-acceptable
partnerships (concordance) between consumers and all
of their healthcare providers.
It seemed that some surveyed consumers had poor
knowledge about the regulation of CAM treatments
available in Australia, stating that CAM available in
Australia have proven effectiveness. This is not true as
CAM currently do not have to have proven effectiveness
in order to be available on the Australian market [53]. It
is unclear how this consumer perception affects the
degree to which they use CAM, as it has been reported
that even when there is no scientific evidence on the
effectiveness of CAM, consumers still tend to continue
to use them [54].
The use of ‘mixed methods’ (i.e. qualitative then quan-
titative methods), combined in this PDS, served to firstly









Medical doctors feel comfortable with their patients seeing CAM practitioners. 8 27 65 78
Pharmacists are knowledgeable about both conventional and CAM medicines. 18 17 65 77
CAM practitioners are sufficiently trained to recognise when CAM are not enough and conventional
medicine needs to be used.
80 11 9 79
There is no need for my CAM practitioners and conventional practitioners to communicate, since the
treatments they provide are different.
18 10 72 81









I feel more satisfied with my partnership with my CAM practitioner than with my partnership with
my pharmacist.
76 10 14 79
I feel more satisfied with my partnership with my CAM practitioner than with my partnership with
my medical doctor.
59 22 19 82
I feel more satisfied with my partnership with my medical doctor than with my partnership with my
pharmacist.
44 32 24 80
I feel more comfortable discussing my concerns about side effects with my CAM practitioner than
with my doctor.
52 22 26 81
I feel more comfortable telling my medical doctor that I am not happy with taking a medicine they
prescribed than I do telling the same to my CAM practitioner.
10 16 74 81
I feel comfortable discussing with my pharmacist all of the issues I might have with my medicines. 57 22 21 81
I feel comfortable discussing with my medical doctor all of the issues I might have with my
medicines.
72 10 18 83
I feel comfortable discussing with my CAM practitioner all of the issues I might have with my
medicines.
81 16 3 80
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extract themes of relevance, and then to formulate these
as specific issues for quantitative comparison with pre-
vious responses by health professionals [10] and for
within-group analysis (i.e. spread of responses amongst
this sample of consumers). One focus group was held to
inform development of the PDS questionnaire from the
self-selected CAM consumers’ perspective, and this pro-
vided a rich source of generated data (in conjunction
with previous focus groups with other health profes-
sional groups [10]), sufficient for the extraction and
development of the themes.
The importance of health-related information sharing
between consumers and healthcare practitioners was
emphasized by this consumer focus group and question-
naire. It should be noted that the intention of this study
was not to explore the nature of the consumers’ rela-
tionship with a specific type of CAM practitioner, how
many CAM practitioners consumers regularly consulted,
nor did it examine their individual experiences with
CAM use.
The limitations of this study included the low
response rate to the questionnaire, and the small num-
ber of participants in the CAM consumer focus group.
The data from the focus group, however, were used in
conjunction with previously collected data [10] to
develop the resulting questionnaire. This single focus
group was not used in isolation. The findings from the
survey, the quantitative part of the PDS reported here,
are not intended to be extrapolated to other consumer
populations, as we recognise that the self-selection was
biased towards users of CAM, and that the response
rate gave a relatively small sample size. From previous
PDS methodology reports, [24-28] it is clear that the
response rates to mailed-back surveys of consumers are
expected to be low or variable [55-58]. Some of the
documented techniques used to improve response rates
were applied in the present study, for example, endorse-
ment by a university, the use of a concise questionnaire,
and administration with a self-addressed envelope for
return. Even using these techniques still only resulted in
a 28% response, which is low. This does, however, give a
window of insight into this self-selected group of CAM
consumers and is valuable for exploring differences
between this group and the perceptions of health profes-
sionals, which could lead to recommendations about
which differences in perceptions need to be attended to
in order to achieve the goal of therapeutic alliances
(’concordance’). Care must be taken not to extrapolate
too widely from these findings. The respondents were
CAM consumers and may have an inherent bias towards
CAM medicines and possibly CAM practitioners (and
likely different opinions on conventional medicines
when compared to non-CAM consumers). Interestingly,
Australian census data, referred to by Xue et al., indicate
that approximately 69% of the population have used
CAM in the preceding 12 months and 44% have visited
a CAM practitioner [42]. Further, in Australia, the esti-
mated number of visits to a CAM practitioner, cited by
Xue et al., is almost identical to the estimated number
of visits to the GP annually (69 million) [42].
The focus of this overall analysis was the consumer,
and the sub-analyses compared and contrasted their
perceptions and opinions on conventional medicine and
CAM; however, this PDS approach is also useful when
compared to other data, collected from other groups, to
determine differences and similarities between groups.
Thus it is useful to briefly consider the main points of
agreement and disagreement of the three previously-sur-
veyed health professional groups (general practitioners,
pharmacists, and CAM practitioners) in relation to the
consumers’ perceived roles [10].
Interestingly, there were numerous statements on
which the majority of participants across all four groups
(including this study’s CAM consumers’ responses)
agreed. Some of these statements have potentially signif-
icant ramifications in terms of their effect on the ways
in which relationships are established and advanced in
healthcare now and into the future. The fact that the
majority of all three practitioner groups and CAM con-
sumers agreed on these statements makes them quite
informative in terms of current shared beliefs and
experiences in the healthcare system:
• Consumers share the same type of personal health
information with all of their healthcare practitioners,
but insufficient information is exchanged between con-
sumers and conventional healthcare practitioners;
• Consumers would lose confidence in treatment if
they did not spend enough time with their healthcare
practitioners;
• Consumers prefer making treatment choices by
themselves when they receive enough information on
treatments from all healthcare practitioners;
• Consumers’ direct involvement in treatment deci-
sions is always valued and they would like to take more
responsibility for their treatments by becoming more
involved in their treatment decision making;
• It is important to inform consumers on their treat-
ment whether it is working for them or not;
• Medical doctors are not comfortable with their
patients seeing CAM practitioners, but there is a need for
CAM and conventional practitioners to communicate;
• Consumers’ choice to use CAM is not respected by
all health practitioners involved in their care.
It is encouraging to note the goodwill in the percep-
tions of the four groups of participants towards further
development of sound relationships. However, some
inconsistency was evident - a majority belief across all
four groups suggested the need for CAM practitioners
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and conventional practitioners to communicate, but at
the same time that medical doctors are not comfortable
with their patients seeing CAM practitioners. Our PDS,
especially the comparisons of the quantitative responses
to the statements from the self-selected CAM consumer
group with data from the conventional and CAM provi-
ders, gives good indications for future areas of research.
Endeavours to move acceptance and understanding
about CAM use by consumers into the realm of conven-
tional medicine can support these areas of mutual
agreement and intervene to dispel areas of misunder-
standing. Identification of these issues and the underly-
ing relationships, potentially leading to concordance
relationships, both for consumers and conventional
medicine practitioners or CAM practitioners, are very
valuable, providing a starting point for further
investigation.
Conclusions
The concept of concordance is based on forming a ther-
apeutic alliance between partners in healthcare. With an
assumption of respect for the consumer’s agenda and
the creation of an atmosphere of openness in the thera-
peutic relationship, consumers and healthcare practi-
tioners can form their relationships on the basis of
reality rather than misunderstanding, distrust and con-
cealment. Perceptions of superiority of either CAM or
conventional medicine can diminish mutual respect
between healthcare practitioners, and, directly or indir-
ectly, influence consumers’ perceptions, communication
and behaviour. This PDS has emphasized the impor-
tance of open communication between consumers,
CAM and conventional providers, and exposed areas
where CAM consumers perceive that issues exist. There
is a lot of information which is perceived as not being
shared at present and there are issues of discomfort and
distrust which require resolution.
It would be warranted to elucidate what exactly are
the perceived ‘positives’ of the CAM paradigm that are
appealing to the consumer, and to apply these in the
development of concordant relationships with all health
practitioners. Our research suggests that the perceived
empowerment and open relationships between consu-
mers and CAM practitioners may be significant issues
warranting further attention. Most of the potentially
problematic issues identified in this study could be
minimised by enhancement of communication between
various health practitioners, and between consumers
and health practitioners. Hence, further research in the
field of concordance should be based on optimisation of
information sharing among the partners and our
research gives indications of some problem areas, identi-
fied by one or more groups. It is recommended that
such research spans both conventional and CAM fields
of healthcare, due to the relevance of concordance prin-
ciples within CAM modalities, and the widespread use
of CAM by consumers. Consequently, further research
evaluating the health systems and potential interventions
enhancing communication from the consumers’ per-
spective would be useful. It is hoped that future
researchers will keep using creative approaches to find-
ing the balance between CAM and conventional aspects
of healthcare in order to optimise relationships between
all stakeholders and improve health outcomes.
Note
The work was carried out at The University of Queens-
land, School of Pharmacy, Brisbane, QLD 4072,
Australia.
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